The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

Cutting edge equipment previously used for COVID testing is now helping Glasgow students in important disease research.

Visby Medical today announced the national launch of the first-of-its-kind FDA-authorized at-home PCR test for sexually transmitted infections (STIs) in women, redefining how sexual health is ...

Flexible multilayer packs protect well but hinder recycling; simpler, compatible designs and credible recovery routes can ...

Pictures of DNA often look very tidy—the strands of the double helix neatly wind around each other, making it seem like ...

According to Precedence Research, the global immunohematology market size will grow from USD 2.86 billion in 2025 to nearly ...

Build return packaging for two journeys: scannable codes, secure seals and right-sized mono-material formats with simple ...

Novartis (NVS) announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156. The novel non-artemisinin antimalarial, ...

ZURICH, November 13, 2025 - Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has extended ...

Mainz Biomed will present its current flagship product, ColoAlert®, a molecular stool-based screening test for the early detection of colorectal cancer, as well as further upcoming diagnostic ...

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation  Around the World SALT LAKE CITY, Nov.

Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...